Related Experiment Video
Updated: Jul 19, 2025

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
Published on: June 13, 2025
Evaluating the Use of Graph Neural Networks and Transfer Learning for Oral Bioavailability Prediction
1School of Chemistry, Chemistry Engineering and Biotechnology, Nanyang Technological University, 21 Nanyang Link, Singapore 637371, Singapore.
Abstract:
Oral bioavailability is a pharmacokinetic property that plays an important role in drug discovery. Recently developed computational models involve the use of molecular descriptors, fingerprints, and conventional machine-learning models. However, determining the type of molecular descriptors requires domain expert knowledge and time for feature selection. With the emergence of the graph neural network (GNN), models can be trained to automatically extract features that they deem important. In this article, we exploited the automatic feature selection of GNN to predict oral bioavailability. To enhance the prediction performance of GNN, we utilized transfer learning by pre-training a model to predict solubility and obtained a final average accuracy of 0.797, an F1 score of 0.840, and an AUC-ROC of 0.867, which outperformed previous studies on predicting oral bioavailability with the same test data set.
Related Concept Videos
Bioavailability: Overview
Determination of Renal Drug Clearance: Graphical and Midpoint Methods
The graphical method involves plotting the rate of drug excretion in urine against the plasma drug concentration. By analyzing the graph, the clearance can be calculated and obtained. Drugs rapidly excreted by the kidneys exhibit a...
Factors Influencing Bioavailability: First-Pass Elimination
Fundamental Mathematical Principles in Pharmacokinetics: Calculus and Graphs
On the other hand, integral calculus focuses on...
Factors Influencing Drug Absorption: Presystemic Elimination
Nonlinear Pharmacokinetics: Bioavailability and Protein-Drug Binding
To quantify the extent of bioavailability, pharmacologists often use a parameter called .

